| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/05/2009 | US20090036425 Substituted bicyclolactam compounds |
| 02/05/2009 | US20090036411 Modulation of cell fates and activities by phthalazinediones |
| 02/05/2009 | US20090036400 Pharmaceutical Preparations for Treating the Consequences of Alcohol Abuse, Hepatitis, Pancreatitis, Alzheimer's Disease, Parkinson's Disease, Diabetes, Toxic Kidney Disease, Reperfusion Damage, Arteriosclerosis, and as an Antidote Against Environmental Toxins and Medicinal Intoxication |
| 02/05/2009 | US20090036383 Compositions and methods for promoting lipid mobilization in humans |
| 02/05/2009 | US20090036381 Treatment of diabetes |
| 02/05/2009 | US20090036375 DBC1, a novel native inhibitor of anti-aging protein SIRT1 |
| 02/05/2009 | US20090036372 treating obesity, diabetes, inflammation, or cancer in a mammal with a biosynthesized protein from culturing microorganisms of algae or bacteria; viral infections, oxidative stress, cardiovascular diseases, immune system disorders, metabolic disorders, HIV, or gastric reflux disease |
| 02/05/2009 | US20090036364 Gip analog and hybrid polypeptides with selectable properties |
| 02/05/2009 | US20090036355 Antisense Modulation of PTP1B Expression |
| 02/05/2009 | US20090036351 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| 02/05/2009 | US20090035397 Methods and compositions for improving cardiovascular risk factors and metabolic risk factors that cause syndrome x |
| 02/05/2009 | US20090035385 Compositions including iron |
| 02/05/2009 | US20090035379 Fenofibrate compositions |
| 02/05/2009 | US20090035367 Controlled degradation of expandable polymers in gastric volume reduction treatment |
| 02/05/2009 | US20090035306 Quinazolinone modulators of tgr5 |
| 02/05/2009 | US20090035297 Methods for treating diabetes |
| 02/05/2009 | US20090035260 Enhanced nasal composition of active peptide |
| 02/05/2009 | US20090035253 Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | CA2697779A1 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid |
| 02/05/2009 | CA2695071A1 The use of benzamide derivatives for the treatment of cns disorders |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694510A1 Treatment with .alpha.7-selective ligands |
| 02/05/2009 | CA2694108A1 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus |
| 02/05/2009 | CA2694098A1 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus |
| 02/05/2009 | CA2687492A1 A herbal composition, method for preparing the same and use thereof for treating diabetes mellitus |
| 02/05/2009 | CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 02/04/2009 | EP2020405A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2020232A1 N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 02/04/2009 | EP2020231A1 Fat absorption inhibitor |
| 02/04/2009 | EP2019824A2 Benzamide glucokinase activators |
| 02/04/2009 | EP2019823A2 Benzamide glucokinase activators |
| 02/04/2009 | EP2019679A2 Glucose transport inhibitors and methods of use |
| 02/04/2009 | EP1660509B1 Glucopyranosyloxy- pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | EP1414410B1 Nanoparticulate formulations of fenofibrate |
| 02/04/2009 | CN101360743A Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators |
| 02/04/2009 | CN101360735A Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 02/04/2009 | CN101357953A Preparation method of sulfated polysaccharides |
| 02/04/2009 | CN101357952A Polysaccharide MA from Mytilus coruscus with hypolipidemic activity and preparation method thereof |
| 02/04/2009 | CN101357924A Dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357923A Dipeptidase inhibitor compound |
| 02/04/2009 | CN101357922A New DPP-IV inhibitor |
| 02/04/2009 | CN101357921A New dipeptidase-IV inhibitor compound |
| 02/04/2009 | CN101357218A Externally used medicine for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357193A Traditional Chinese medicine for treating hypertension and hyperlipemia and its preparation method |
| 02/04/2009 | CN101357183A Medicine containing citrus aurantium for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357182A Medicine containing dark plum for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357181A Medicine containing bupleurum root for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357180A Medicine containing trichosanthes root for treating diabetes and preparation method thereof |
| 02/04/2009 | CN101357174A Medicinal composition for treating diabetes |
| 02/04/2009 | CN101357157A Preparation for increasing the body fluid |
| 02/04/2009 | CN101357156A Traditional Chinese medicine for curing diabetes and preparation method thereof |
| 02/04/2009 | CN101357152A Epiphyllum oxypetalum medicinal preparation |
| 02/04/2009 | CN101357144A Selaginella uncinata extraction, its preparation method and application |
| 02/04/2009 | CN101357142A Use of Clostridium butyricum in preparing medicine composition for preventing and treating cerebrovascular disease |
| 02/04/2009 | CN101357141A Water-soluble mixing active pearl calcium and preparation method thereof |
| 02/04/2009 | CN101357140A Vitamin-adding high-peptide pearl active calcium replenishing agent and preparation method thereof |
| 02/04/2009 | CN101357139A Multivitamin selenium-enriched active pearl oral preparation and preparation method thereof |
| 02/04/2009 | CN101357133A Composition for treating hyperlipemia |
| 02/04/2009 | CN101357132A Composition for treating hyperlipemia |
| 02/04/2009 | CN101357131A Composition for treating hyperlipemia |
| 02/04/2009 | CN101357029A Peony massaging pillow and production method thereof |
| 02/04/2009 | CN101356980A Preparation method of fish liver hydrolysate and use thereof |
| 02/04/2009 | CN101356969A Health food containing pearl and kudzuvine root and its preparation method |
| 02/04/2009 | CN101356968A Red Chinese fevervine extract and medical composition thereof and food composition and preparation method thereof |
| 02/04/2009 | CN101356961A Corn weight-reducing food |
| 02/04/2009 | CN100457895C Mouse anti-human macrophage migration inhibiting factor monoclonal antibody and its application |
| 02/04/2009 | CN100457879C Process for preparing vegetable oil fractions rich in non-tocolic high-melting, unsaponifiable matter |
| 02/04/2009 | CN100457778C Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457730C Indoles having anti-diabetic activity |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457184C Multi-stage oral drug controlled-release system |
| 02/04/2009 | CN100457141C Lipid-lowering cassia capsule and its preparing method |
| 02/04/2009 | CN100457134C Method for preparing extractive of Jumi |
| 02/04/2009 | CN100457131C Dripping pills of erigeron breviscapus and its preparation method |
| 02/04/2009 | CN100457108C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 02/04/2009 | CN100457106C Use of 1-deoxynojirimycin for preparing diabete and disney disease drug |
| 02/04/2009 | CN100457102C Pharmaceutical compositions |
| 02/04/2009 | CN100457097C Composition for lowering blood glucose |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100457086C Aseptic medicine composition |
| 02/04/2009 | CN100457078C Cosmetics |
| 02/04/2009 | CN100456963C Protein nutrition flour containing Chinese date and its processing method |
| 02/04/2009 | CN100456946C Oilseed processing |
| 02/03/2009 | US7485755 Acid addition salt of carbasugar amine derivative |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485662 for improving insulin resistance; food and drink additives, and feeds or feed additives for treating diabetes mellitus; cis-4-hydroxy-L-proline, cis-4-hydroxy-D-proline, cis-3-hydroxy-L-proline, cis-3-hydroxy-D-proline, trans-4-hydroxy-L-proline, trans-4-hydroxy-D-proline, trans-3-hydroxy-L-proline ETC. |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485641 Substituted 3-amino-pyrrolidino-4-lactams |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |